New hope for Moms-to-Be: safer malaria drugs tested in landmark trial

NCT ID NCT06962319

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests newer antimalarial drugs to see if they work as well as the current standard treatment for malaria in early pregnancy. It involves 1,510 pregnant women in Africa. The goal is to find treatments that are both effective and safe for the mother and baby.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA, PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malaria Plasmodium falciparum malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO)

    NOT_YET_RECRUITING

    Nanoro, Burkina Faso

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • KEMRI Centre for Global Health Research (CGHR)

    NOT_YET_RECRUITING

    Kisumu, 40100, Kenya

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

  • Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako (USTTB),

    RECRUITING

    Bamako, 1805, Mali

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••